24 results on '"Touma, Zahi"'
Search Results
2. 205 Longitudinal immune changes during and after recent flares in lupus
3. 402 Serum cytokine profiling reveals elevated levels of S100A8/A9 and MMP-9 in systemic lupus erythematosus patients with cognitive impairment independently of disease activity and inflammatory markers
4. 1116 Long-term ocular safety of hydroxychloroquine in patients with childhood-onset SLE (cSLE) followed into adulthood
5. 1501 Genetics of age at systemic lupus erythematosus diagnosis
6. 1303 The new EULAR/ACR 2019 SLE classification criteria: a predictor of long-term outcomes
7. 601 An imbalance between regulatory and pro-inflammatory T cell subsets distinguishes symptomatic from asymptomatic individuals with anti-nuclear antibodies
8. 1117 SLE phenotypes formed from machine learning and their associations with cognitive impairment
9. O8 Performance of the EULAR/ACR 2019 classification criteria for systemic lupus erythematosus in men, ethnicities, and early disease
10. FRI0178 CLUSTER PROFILING OF PATIENTS IN A REAL-WORLD DATA SET WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THEIR ASSOCIATED TREATMENTS
11. THU0688 ASSESSMENT OF THE QRISK2, QRISK3, SLE CARDIOVASCULAR RISK EQUATION, FRAMINGHAM AND MODIFIED FRAMINGHAM RISK CALCULATORS AS PREDICTORS OF CARDIOVASCULAR DISEASE EVENTS IN SYSTEMIC LUPUS ERYTHEMATOSUS
12. FRI0189 POOLED ANALYSIS OF THE REAL-WORLD EFFECTIVENESS OF BELIMUMAB IN TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS USING MULTI-COUNTRY DATA FROM THE OBSERVE STUDIES
13. THU0250 EARLY IMPROVEMENT IN SLEDAI-2K RESPONDER INDEX-50 PREDICTS SRI-4 RESPONSE IN A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF USTEKINUMAB (UST) IN SYSTEMIC LUPUS ERYTHEMATOSUS
14. FRI0256 ASSESSING THE PREVALENCE AND USE OF VALIDATED SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY METRICS IN REAL WORLD PRACTICE
15. FRI0669 DEPRESSION AND ANXIETY AND THEIR CLINICAL CORRELATES IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
16. AB0486 LACK OF CONSISTENT STANDARD OF CARE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS IN REAL WORLD
17. 60 Association of systemic lupus erythematosus (SLE) genetic susceptibility loci with lupus nephritis in childhood-onset and adult-onset with SLE
18. 10 Performance of SLEDAI-2K Responder Index-50 in a Randomized Placebo-Controlled Trial with Ustekinumab (UST) in Systemic Lupus Erythematosus
19. 291 Assessment of the QRISK2, QRISK3, SLE cardiovascular risk equation, modified framingham and framingham risk calculators as predictors of cardiovascular disease events in systemic lupus erythematosus
20. CS-36 Recommendations for the assessment of systemic lupus erythematosus in canada
21. AI-09 T follicular helper (Tfh) cells are increased in asymptomatic anti-nuclear antibody (ANA)+ individuals and appear to play a role in epitope spreading
22. CS-37 Prevalence of cognitive impairment in systemic lupus erythematosus assessed by a comprehensive neuropsychological battery
23. CS-22 Confirmatory factor analysis of the patient-reported perceived deficits questionnaire in systemic lupus erythematous: cautions for use of subscales
24. CE-36 Clinical measures and indices of disease activity and damage as predictors of morbidity and mortality in systemic lupus erythematosus (SLE): a systematic review of the literature
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.